External Defibrillators Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Manual, Automated, Wearable Cardioverter Defibrillators), By End Use (Hospital, Pre-Hospital, Public Access Market), By Region, And Segment Forecasts

External Defibrillators Market Summary

The global external defibrillators market size was estimated at USD 4.22 billion in 2025 and is projected to reach USD 8.90 billion by 2033, growing at a CAGR of 9.80% from 2026 to 2033. Market growth is driven by the rising prevalence of cardiovascular diseases, technological innovations, and government initiatives to place automated external defibrillators in public spaces.

Widespread use of external defibrillators in hospitals, nursing facilities, and home care is expected to further support market expansion during the forecast period. Increasing awareness of sudden cardiac arrest and growing emphasis on early intervention are also contributing to higher adoption rates across both clinical and public settings. In March 2024, Stryker unveiled a new automated external defibrillator, the LIFEPAK CR2, at the Criticare National Conference in Kolkata, designed to provide guided CPR and rapid shock delivery for cardiac emergencies. The company also introduced an evacuation chair to enable safer and faster movement of patients during emergency situations.

Introduction of technological innovations in defibrillators is driving the market growth. AEDs have been upgraded with numerous new features, such as LCD screens, rechargeable batteries, voice prompts, and new types of shocks. As a result, vendors have been focusing more and more on the development of innovative AEDs. For instance, in January 2023, Avive Solutions, Inc. received U.S. FDA premarket approval for its device, Avive AED. The device features cellular, WiFi, GPS, and Bluetooth connectivity. This connectivity enables users to transfer incident data to 911 centers. Furthermore, in July 2023, OOONO Medical and Corscience partnered to develop the world’s smallest AED named Joule.

Some of the key technological advancements expected to boost market growth are:

• Integration of the Internet of Things (IoT) & Artificial Intelligence (AI) to allow real-time monitoring, data transmission, & accurate assessments, enhancing medical interventions.

• Multifunctionality features, such as CPR feedback and oxygen administration, to support resuscitation efforts.

• Portable defibrillators are expected to be more compact and user-friendly, increasing their consumer penetration in general life settings.

• Augmented Reality (AR) and Virtual Reality (VR) can be integrated into AED training to provide real-life scenarios.

In March 2023, Federal lawmakers in the U.S. introduced the Access to AEDs Act, which addresses SCAs in athletes by creating a grant program in elementary and secondary schools to purchase, maintain, and provide training related to AEDs. Furthermore, in December 2022, the Department of Health and Social Care in the UK announced a USD 1.27 million (GBP 1 million) fund to increase the number of AEDs in communities nationwide. This budget was expected to aid in the purchase of 1,000 new defibrillator machines.

Despite advancements in treatment and prevention, SCA remains a primary cause of death, accounting for roughly more than half of all cardiovascular-related deaths. The growing prevalence of SCA, one of the major causes of deaths worldwide, and its risk factors is projected to drive the demand for AEDs. SCA is the leading cause of natural deaths in the U.S., accounting for approximately 325,000 adult deaths each year. It is also responsible for 50% of all heart-related deaths.

Moreover, a significant correlation between high blood pressure and its negative effect on left ventricular hypertrophy is expected to drive the market growth for defibrillators over the forecast period. As per a report from the British Heart Foundation in 2023, 28% of the country’s adult population suffers from high blood pressure. 

Automated External Defibrillators (AEDs) are life-saving devices designed to quickly restore normal heart rhythm in cases of sudden cardiac arrest. Compact, easy to use, and often equipped with voice or visual prompts, AEDs enable both trained and untrained bystanders to provide immediate assistance, significantly improving survival rates in emergencies outside of hospitals. In January 2026, Heartstream launched as an independent company focused on defibrillators, following its acquisition of Philips’ Emergency Care business. The company aims to expand AED access in public and home settings, enhancing emergency response and improving survival rates from sudden cardiac arrest.

Market Concentration & Characteristics

The global external defibrillators industry demonstrates a high degree of innovation, driven by advancements in automated external defibrillator (AED) technology, improved battery life, enhanced portability, real-time connectivity, and integration with digital health platforms. Continuous R&D focuses on making devices faster, smarter, and more user-friendly, enabling rapid response in both clinical and out-of-hospital cardiac emergencies. In December 2025, Everdrone launched France’s first drone-based emergency medical service in Normandy, delivering automated external defibrillators (AEDs) directly to suspected cardiac arrest cases via emergency dispatch, often arriving before ambulances to improve survival outcomes.

Leading players such as Abbott, Medtronic, Stryker, Boston Scientific, and Philips engage in mergers, acquisitions, and strategic partnerships to enhance product portfolios, enter new markets, and accelerate technological development. In June 2025, Bridgepoint announced it would acquire a controlling stake in Safe Life, a global leader in AED distribution, valuing the company at approximately USD 540 million. The partnership aims to expand access to automated external defibrillators across North America and Europe, supported by training, maintenance, and replacement services in a highly fragmented, fast-growing market focused on public and workplace AED deployment.

Regulatory frameworks from the U.S. FDA, European Medicines Agency (EMA), and other regional authorities strongly influence the external defibrillators industry. Strict approval requirements ensure safety and therapeutic efficacy, often lengthening development timelines and increasing costs. Simultaneously, evolving pathways such as expedited review programs, digital health approvals, and real-world evidence requirements enable faster introduction of connected and next-generation devices.

External defibrillators currently have no direct substitutes. While standard ECGs, wearable monitors, and periodic clinical assessments provide diagnostic information, they cannot deliver immediate therapeutic intervention in cases of sudden cardiac arrest. The unique combination of continuous monitoring, rapid shock delivery, and user-friendly automation makes external defibrillators indispensable in both hospital and community settings.

Manufacturers are actively targeting untapped regional markets, partnering with local distributors, and tailoring solutions to meet regional healthcare infrastructure and emergency response needs. Expansion efforts focus on increasing AED accessibility in public spaces, rural areas, and emerging economies, enhancing patient outcomes through timely defibrillation and training programs.

Product Insights

Based on product, the automated external defibrillator segment dominated the market with the largest revenue share of 39.51% in 2025. This can be attributed to the rising prevalence of lifestyle diseases such as hypertension, obesity, diabetes, and dyslipidemia, which are major risk factors for developing cardiovascular disease. Key players operating in the market are constantly focusing on gaining FDA approvals to launch and distribute their products in the market and are undertaking initiatives to enhance the adoption of external defibrillators. In April 2024, Avive Solutions closed a USD 56.5 million growth equity financing round to accelerate the deployment of its connected AED ecosystem and expand its commercial operations across the U.S. The funding will support nationwide scaling of its Avive Connect AED and networked response platform designed to shorten response times and improve survival rates in out‑of‑hospital cardiac arrest emergencies.

The manual external defibrillator segment is anticipated to grow at a significant CAGR over the forecast period. A manual external defibrillator is a medical device that delivers an electric shock to the heart to treat abnormal heart rhythms. It is often used in emergencies, such as cardiac arrest or other life-threatening heart rhythms. The increasing prevalence of cardiovascular disease is a major driver of market growth. According to American Heart Association, there were 356,000 sudden cardiac arrests reported in 2022 and 65% of deaths were in people aged 75 & above, 6% of deaths in the age group of 25 to 54 years, and 29% in the age group of 55 to 74 years.

End Use Insights

In terms of end use, the hospital segment dominated the market with a revenue share of 53.43% in 2024. This is owing to most facilities and medical devices, such as automated external defibrillators, being available in hospitals for treating & diagnosing cardiovascular disease. The rising demand for external defibrillator devices for patients with cardiovascular disease and congestive heart failure is another factor propelling the market growth. In March 2024, SCHILLER launched its FRED easy G2 automated external defibrillator, tailored for hospital and clinical environments. Featuring semi-automatic and fully automatic modes, a 5” touch screen, CPR guidance, and integrated pediatric support, the device ensures fast, reliable, and user-friendly intervention in time-critical cardiac emergencies within healthcare facilities.

The public access market segment is expected to grow at the fastest CAGR over the forecast period. The increasing prevalence of sudden cardiac arrest is a major factor supporting the growth of this segment. The public access market segment includes untrained & trained personnel and bystanders who specifically use automated external defibrillator devices in treating sudden out-of-hospital cardiac arrest. In June 2024[TS7] , Hato Hone St John partnered with ViVest to launch New Zealand’s first branded AEDs, the PowerBeat X1 and X3, designed for rapid shock delivery within seven seconds. The devices feature intuitive visual and verbal instructions, child mode, and a lightweight, compact design, aiming to improve public access to life-saving technology and increase survival rates from out-of-hospital cardiac arrests.

Regional Insights

North America external defibrillators industry dominated the global market with a revenue share of 41.95% in 2025. The region is anticipated to register lucrative growth owing to initiatives that promote the deployment of public access AEDs and other development efforts by key market players. For instance, in January 2023, Avive Solutions, Inc. obtained premarket approval from the U.S. FDA for its Avive AED, an innovative AED. The company estimates that over 4 million AEDs have been deployed nationwide, aiming to offer speedy and life-saving support during Out-of-Hospital Cardiac Arrest (OHCA).

U.S. External Defibrillators Market Trends

The U.S. external defibrillators industry dominated the North America region in 2025. Many national organizations, including the American Heart Association (AHA), recommend the implementation of comprehensive Public Access Defibrillation (PAD) programs. The suggested attributes for such a program include targeted placement of AEDs (including their routine maintenance & testing), imparting training to responders, Emergency Medical Services (EMS) coordination, and continuous quality improvement. By 2022, 20 states had laws that required targeted AED placement in schools, while nearly 14 states require AEDs in health clubs. Moreover, 22 states necessitate AED placement in dental. Changing dynamics in public policies is anticipated to propel the demand for AEDs.

Europe External Defibrillators Market Trends

The external defibrillators industry in Europe is expected to grow significantly over the forecast period. This can be attributed to well-established healthcare infrastructure, large geriatric population susceptible to cardiovascular adverse events, and the local presence of key companies. In addition, the high incidence of OHCA in Europe, coupled with the low survival rate, is boosting the demand for more accessible and available AEDs. According to a 2023 EENA report, SCA is the third-leading cause of death in Europe. Most of these SCAs are OHCA. The incidence of OHCA in Europe is between 67 and 170 per 100,000 inhabitants and the average survival rate is 8% to 10%.

The external defibrillators industry in the UK is expected to grow significantly during the forecast period. The growing initiatives to promote access to and use of defibrillators, coupled with the need for timely intervention during SCA, and the strategic initiatives undertaken by global companies are expected to contribute to the UK's large market share in 2023. For instance, HeartSafe AED Locator tracks and displays the location of registered public access defibrillators across the UK. It also recommends the use of HeartSine line of defibrillators manufactured by HeartSine Technologies Ltd. (owned by Stryker).

Asia Pacific External Defibrillators Market Trends

The Asia Pacific external defibrillators industry is expected to register the fastest growth rate over the forecast period due to the presence of leading companies, high adoption of external defibrillators in key markets, and growing penetration in developing markets. Zoll, a part of Asahi Kasei, has an extensive portfolio and distribution network and is a leading company in the global market for external defibrillators.

China's external defibrillators industry is anticipated to grow considerably during the forecast period, driven by the increasing prevalence of cardiovascular diseases and a rapidly aging population. Ongoing healthcare infrastructure modernization and rising adoption of advanced diagnostic and monitoring technologies are expected to further support market growth.

Latin America External Defibrillators Market Trends

The Latin America external defibrillators industry is anticipated to witness a considerable growth over the forecast period driven by the growing awareness about cardiac arrest and increasing regulatory frameworks to support the availability of AEDs in public & private places. According to the American Heart Association, Inc., more Latin American countries are developing supportive regulatory frameworks to increase the availability of AEDs in high-traffic locations. Countries such as Colombia, Panama, Chile, Argentina, Puerto Rico, and Uruguay have already implemented similar laws to regulate the use of AEDs.

Argentina's external defibrillators industry is anticipated to register considerable growth during the forecast period, supported by growing awareness of sudden cardiac arrest and improvements in emergency medical response systems. Expanding deployment of automated external defibrillators in public spaces and increased private sector healthcare investment are contributing to market expansion.

Middle East External Defibrillators Market Trends

The Middle East and Africa external defibrillators industry is anticipated to witness considerable growth over the forecast period, fueled by improving healthcare infrastructure, growing deployment of defibrillators, and increasing awareness about sudden cardiovascular events.

The UAE external defibrillators industry is anticipated to grow considerably during the forecast period, owing to strong healthcare expenditure and stringent safety and emergency preparedness regulations. Increased installation of automated external defibrillators across public, commercial, and transportation facilities is expected to drive sustained market growth.

Key External Defibrillators Company Insights

Key participants in the external defibrillators devices industry focus on devising innovative business growth strategies, such as expanding their product portfolios, partnerships and collaborations, mergers and acquisitions, and business footprints. In January 2026, WSIB launched a rebate program giving Ontario construction businesses up to USD 1,800 for automated external defibrillators (AEDs), supporting rapid response to out-of-hospital cardiac arrests.

Recent Developments

• In September 2025, Avive Solutions received approval for its Avive Connect AED for use on aircraft, making it the smallest and lightest AED available for in-flight emergencies. The device features remote monitoring, real-time incident reporting, and intuitive rescue guidance, enabling safer and faster response to sudden cardiac arrest in aviation and other mobile environments.

• In October 2024, Avive Solutions launched QuickRescue, a new feature for its Avive Connect AED that transmits real-time incident data to 911 operators, enabling faster and more informed emergency response during sudden cardiac arrest. The feature, developed in partnership with RapidSOS, provides location, patient status, and shock information to first responders, enhancing survival outcomes in out-of-hospital cardiac emergencies.

• In June 2024, CU Medical’s new AED product, the LiFEGAIN CU-RS100, won Germany’s Red Dot Design Award for Concept Design in Medical Devices and Technology, recognizing its lightweight, durable, and portable design suitable for marine and emergency environments. The device features an intuitive user interface and enhanced usability, reinforcing CU Medical’s commitment to innovation and global market expansion.

External Defibrillators Market Report Scope

Global External Defibrillators Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global external defibrillators market report based on product, end use, and region:

• Product Outlook ((Unit Volume, Thousand Units; Revenue in USD Million, Average Selling Price [USD per Unit]), 2021 - 2033)

  • Manual External Defibrillators

  • Automated External Defibrillators

    • Semi-Automated ED

    • Fully Automated ED

  • Wearable Cardioverter Defibrillators

• End Use Outlook ((Unit Volume, Thousand Units; Revenue in USD Million, Average Selling Price [USD per Unit]), 2021 - 2033)

  • Hospital

  • Pre Hospital

  • Public Access Market

  • Alternate Care Market

  • Home Healthcare

• Regional Outlook ((Unit Volume, Thousand Units; Revenue in USD Million, Average Selling Price [USD per Unit]), 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait